Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 40 of 5804
-
New brain zaps could lift postpartum depression in days
Symptom relief Recruiting nowThis study is a large, multi-site clinical trial testing whether Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), a fast-acting form of repetitive transcranial magnetic stimulation (rTMS), can more effectively reduce symptoms of postpartum depression (PPD) compar…
Phase: NA • Sponsor: Magnus Medical • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Could your own fat cells fight Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThe goal of this Phase 2 clinical trial is to learn if repeated dosing of RB-ADSC (an investigational autologous cell product obtained from participant's own adipose tissue) enhances the positive preliminary results seen in Phase 1 for the of treatment for mild to moderate Alzhei…
Phase: PHASE2 • Sponsor: Regeneration Biomedical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
One shot to save tiny brains: new trial for preemies
Prevention Not yet recruitingIn Canada, about 900 babies each year are born very early (\<26 weeks of gestation) and have a high chance of dying or having a serious bleed in the brain. Families of these extremely preterm babies consider preventing severe brain bleeding as critical to their child's health and…
Phase: PHASE2 • Sponsor: University of British Columbia • Aim: Prevention
Last updated Jun 26, 2026 13:03 UTC
-
New drug cocktail shows promise for advanced liver cancer
Disease control Recruiting nowThis is a multi-center randomized phase III clinical study of first-line Camrelizumab and Apatinib with or without intravenous FOLFOX Chemotherapy for Advanced Hepatocellular Carcinoma (HCC).
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for lung cancer patients: targeted drug Dato-DXd faces off against chemo
Disease control Recruiting nowTROPION-Lung17 will measure the efficacy and safety of datopotamab deruxtecan (Dato-DXd) compared with docetaxel in patients with trophoblast cell surface protein 2 (TROP2) positive advanced or metastatic lung cancer without actionable genomic alterations (AGA).
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug cocktail aims to outsmart lung cancer in major trial
Disease control Recruiting nowThis study is a randomized, controlled, open-label, multicenter Phase III clinical trial designed to compare the efficacy and safety of SHR-A2009 combined with aumolertinib versus aumolertinib monotherapy in treatment-naïve subjects with EGFR-mutated, locally advanced or metastat…
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for Hard-to-Treat breast cancer: BNT327 combo enters phase 3 trial
Disease control Recruiting nowThis is a Phase III trial where participants will be randomized to two treatment groups, which means participants will be assigned by equal chance to a treatment group. This trial will be double-blinded, which means neither the participants nor the trial doctors will know which o…
Phase: PHASE3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
One-Dose antibiotic could slash ventilator pneumonia deaths in brain injury patients
Prevention Recruiting nowThis research is about whether treatment with a commonly used antibiotic can prevent infections in airway and lungs and improves the chance of surviving, if it is given soon after patients commence mechanical ventilation when they have been admitted to hospital with an acute seve…
Phase: PHASE3 • Sponsor: The George Institute • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
New drug aims to reverse liver damage in MASH patients
Disease control Recruiting nowThe purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis and improvement of liver-related clinical outcome compared to placebo in individuals with MASH and biopsy-confirmed F2- or F3-stage fibrosis.
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo aims to outperform chemo for tough lung cancer
Disease control Recruiting nowThis clinical trial is designed to assess the efficacy and safety of trastuzumab deruxtecan (T-DXd; Enhertu®) in combination with pembrolizumab versus platinum-based chemotherapy in combination with pembrolizumab in participants with no prior therapy for locally advanced unresect…
Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New minimally invasive procedure could change outcomes for bleeding stroke patients
Disease control Recruiting nowTIME-ICH (TrIal of early Minimally Invasive catheter Evacuation with thrombolysis in IntraCerebral Hemorrhage) is a multicenter, randomized, adaptive clinical trial comparing best medical management to early minimally invasive surgery with thrombolysis (eMIST) in the treatment of…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for KRAS lung cancer: targeted combo takes on chemo in major trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of divarasib and pembrolizumab compared with pembrolizumab and pemetrexed and carboplatin or cisplatin, for the first-line treatment of adult participants with KRAS G12C-mutated, advanced or metastatic non squamous …
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug aims to shrink HER2 breast tumors before surgery
Disease control Recruiting nowThis study is a multicenter, randomized, open-label, parallel Phase III clinical trial. 650 early-stage or locally advanced breast cancer participants will be enrolled and randomly assigned to SHR-A1811 monotherapy group (trial group) or TCbHP treatment group (control group) at a…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Gene therapy trial aims to help boys with duchenne walk stronger
Disease control Recruiting nowThis is a Phase 3, double-blind, placebo-controlled study with the primary objective of evaluating the efficacy of a single IV infusion of SGT-003 in pediatric ambulant male participants with DMD. The secondary objectives include the evaluation of additional efficacy and safety o…
Phase: PHASE3 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New lung cancer cocktail aims to outperform current standard
Disease control Recruiting nowThis study is a randomized, open-label, controlled, multicenter Phase III clinical trial to evaluate the efficacy and safety of SHR-8068 combined with adebrelimab and platinum-based chemotherapy versus tislelizumab combined with platinum-based chemotherapy as first-line treatment…
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Triple therapy aims to cure High-Risk skin cancer without disfigurement
⭐️ CURE ⭐️ Recruiting nowBasal cutaneous cell carcinoma (BCC) is the most common skin cancer. Early-stage disease is managed with surgery or radiation that cure more than 95% of patients. Surgical excision is the treatment of choice and by far the most convenient and effective means of achieving cure of …
Phase: PHASE1, PHASE2 • Sponsor: Instituto Oncológico Dr Rosell • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 08:00 UTC
-
Could a simple breath test catch pancreatic cancer sooner?
Diagnosis Recruiting nowThe investigators are developing a non-invasive breath test to help us detect pancreatic cancer earlier. The test detects small molecules called volatile organic compounds that are made by pancreatic cancers. Pancreatic cancer is a rare disease but patients are often diagnosed a…
Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
New hope for Late-Stroke patients: drug before procedure may boost recovery
Disease control Recruiting nowThis randomized, double-blind, placebo-controlled phase III clinical trial aims to evaluate the efficacy and safety of intravenous recombinant human tenecteplase (rhTNK-tPA) in acute ischemic stroke patients with large vessel occlusion presenting 4.5-24 hours after last known wel…
Phase: PHASE3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug combo aims to eliminate rectal tumors before surgery
Disease control Recruiting nowThe goal of this clinical trial is to evaluating the efficacy and safety of radiotherapy combined with Tislelizumab, Liposomal Irinotecan, and Capecitabine in patients with locally advanced mid-lower rectal cancer with pMMR.. Patients would be included as:1. Aged between 18-75 ye…
Phase: PHASE2 • Sponsor: Affiliated Cancer Hospital of Shantou University Medical College • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Personalized chemo boosts CAR T-Cell success in young leukemia patients
Disease control Recruiting nowThe researchers are doing this study to find out whether PK-targeted fludarabine is an effective Lymphodepletion (LD) chemotherapy approach for people with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) who will receive tisagenlecleucel CAR T-cell therapy. The re…
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC